FF
SAGE

FourThought Financial’s Sage Therapeutics SAGE Stock Holding History

FourThought Financial’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$5K Hold
138
– – ﹤0.01% 1178
2022
Q2 		$4K Hold
138
– – ﹤0.01% 1216
2022
Q1 		$5K Hold
138
– – ﹤0.01% 1201
2021
Q4 		$6K Sell
138
-69
-33% -$2.89K ﹤0.01% 1185
2021
Q3 		$9K Sell
207
-34
-14% -$1.56K ﹤0.01% 1124
2021
Q2 		$13K Hold
241
– – ﹤0.01% 1054
2021
Q1 		$18K Hold
241
– – ﹤0.01% 927
2020
Q4 		$20K Buy
+241
New +$17.8K ﹤0.01% 878

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FourThought Financial's SAGE Position: Q3 2022 in Review

FourThought Financial held its Sage Therapeutics (SAGE) position steady in Q3 2022 at 138 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

FourThought Financial first reported a position in SAGE in Q4 2020 and has held it in 8 quarters since. The position peaked at $20K in Q4 2020. 201 funds tracked by Wall St. Rank hold SAGE as of Q3 2022.

  • FourThought Financial held 138 shares of Sage Therapeutics worth $5K as of Q3 2022.
  • FourThought Financial left its Sage Therapeutics share count unchanged in Q3 2022.
  • Sage Therapeutics made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1178 holding.
  • FourThought Financial first reported a position in Sage Therapeutics in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's Sage Therapeutics position peaked at $20K in Q4 2020.
  • 201 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.